Click the links below to find more information:
Wednesday October 7, 2015"New Sites and Modes of Melanocortin Action". Presented by:Roger D. Cone, Ph.D.Professor and ChairDepartment of Molecular Physiology and BiophysicsDirector, Vanderbilt Institute for Obesity and MetabolismVanderbilt University School of MedicineNashville, TNPlease click here for more information
The Obesity, Cardiorenal, Metabolic Diseases Center (OCMDC) at the University of Mississippi Medical Center is supported by a five-year award (P20GM104357) from the National Institute of General Medical Sciences (NIGMS). The NIGMS is a part of the National Institutes of Health (NIH) that supports thematic, multidisciplinary Centers of Biomedical Research Excellence (COBRE) across the country through its Institutional Development Award (IDeA) program.
Cardiovascular, renal and metabolic diseases are inextricably linked and are the leading causes of mortality and morbidity in the United States, especially in Mississippi which has the highest prevalence in the nation of these diseases. These disorders usually cluster together and are highly interdependent. For example, obesity and associated metabolic disorders, such as diabetes, are major causes of cardiovascular and renal disease. A major objective in developing the Obesity, Cardiorenal and Metabolic Diseases Center (OCMDC) is to provide infrastructure for a multidisciplinary, diverse group of basic, clinical and population scientists working on the common synergistic theme of obesity, cardiorenal and metabolic diseases and to facilitate their collaborations.
2500 North State Street
Jackson, MS 39216
General Information: 601-984-1000
Patient Appointments: 888-815-2005